Study Participants’ and Clinicians’ Experiences With Placement of a Novel Low-Dose Copper Intrauterine Device With a Nitinol Frame in Nulliparous vs. Parous Participants - OP02B

Sunday, May 21, 2023

1:00 PM – 2:00 PM ET

Location: Room 307

Sub Topic: Contraception

AR

Andrea H. Roe, MD (she/her/hers)

Assistant Professor
Penn Medicine
Philadelphia

Disclosure information not submitted.
CM

Colleen P. McNicholas, DO (she/her/hers)

Chief Medical Officer
Planned Parenthood of the St. Louis Region
St. Louis, MO, U.S.

Disclosure(s): No financial relationships to disclose

Disclosure(s):

David K. Turok, MD: Bayer Women's Healthcare: University Grants/Research Support (Ongoing); Cooper Surgical: University Grants/Research Support (Ongoing); Medicines360: University Grants/Research Support (Ongoing); Organon: University Grants/Research Support (Ongoing); Sebela Pharmaceuticals: Consultant (Ongoing), University Grants/Research Support (Ongoing)

Colleen P. McNicholas, DO: No financial relationships to disclose